Skip to Main Content
Skip Nav Destination

The adoption of small-molecule biomarker-driven approaches in clinical decision-making has substantially enhanced the safety and effectiveness of specific therapeutic interventions. Fluorescent probes have gained significant recognition as essential chemical tools for detecting small molecules. Small-molecule fluorescent probes offer numerous benefits, including cost-effectiveness, ease of synthesis and storage, and considerable flexibility in probe design. Importantly, they typically induce minimal disturbance to the native target within complex environments. To date, hundreds of targeted small molecules are in surveillance pipelines. This chapter provides a brief overview of the recently discovered four categories and ten types of low-cost small molecules and their corresponding indicators in diagnosing cancers, diabetes mellitus, hypertension, depressive disorder, etc.

You do not currently have access to this chapter, but see below options to check access via your institution or sign in to purchase.
Don't already have an account? Register
Close Modal

or Create an Account

Close Modal
Close Modal